文献速递脑血管病神经重症与神经感染

平扫CT征象预测急性脑出血血肿扩大、临床结局及氨甲环酸反应

Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2019-11-18

基于TICH-2随机对照试验2077例急性脑出血患者,分析平扫CT征象(blend征、黑洞征、岛征、低密度影)对血肿扩大和90天不良功能结局的预测价值。结果显示blend征、黑洞征和低密度影独立预测血肿扩大,黑洞征、低密度影和岛征预测不良功能结局;氨甲环酸降低血肿扩大风险,但CT征象与氨甲环酸疗效无显著交互作用。

要点

  • blend征、黑洞征和低密度影是血肿扩大的独立预测因素。
  • 黑洞征、低密度影和岛征预测90天不良功能结局。
  • 平扫CT征象不能预测氨甲环酸更好的疗效反应。

核心结论

  • blend征、黑洞征和低密度影预测血肿扩大,黑洞征、低密度影和岛征预测不良功能结局。
  • 平扫CT征象未预测氨甲环酸更好的反应。

研究设计与样本

  • TICH-2为前瞻性随机对照试验,探索氨甲环酸在急性脑出血中的疗效与安全性。
  • 共纳入2325例患者,其中2077例(89.3%)有有效基线和24小时CT扫描。

主要发现

  • blend征患病率16.1%(366例),黑洞征18.2%(414例),岛征8.8%(200例),低密度影30.2%(701例)。
  • 多变量分析:blend征aOR 1.53(95%CI 1.16-2.03,P=0.003)、黑洞征aOR 2.03(1.34-3.08,P=0.001)、低密度影aOR 2.06(1.48-2.89,P<0.001)独立预测血肿扩大。
  • 黑洞征aOR 1.52(1.10-2.11,P=0.012)、低密度影aOR 1.37(1.05-1.78,P=0.019)、岛征aOR 2.59(1.21-5.55,P=0.014)预测不良功能结局。
  • 氨甲环酸降低血肿扩大风险aOR 0.77(0.63-0.94,P=0.010),CT征象与氨甲环酸疗效交互作用P均>0.05。

关键数值与推荐

  • 血肿扩大定义为24小时CT血肿体积增加>33%或>6 mL。
  • 不良功能结局定义为90天改良Rankin量表4-6分。

临床怎么用

  • 可用blend征、黑洞征和低密度影辅助识别血肿扩大高危患者。
  • 黑洞征、低密度影和岛征可帮助预判90天不良功能结局。
  • 不应依据平扫CT征象选择氨甲环酸治疗获益人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Blend, black hole, island signs, and hypodensities are reported to predict hematoma expansion in acute intracerebral hemorrhage. We explored the value of these noncontrast computed tomography signs in predicting hematoma expansion and functional outcome in our cohort of intracerebral hemorrhage. Methods- The TICH-2 (Tranexamic acid for IntraCerebral Hemorrhage-2) was a prospective randomized controlled trial exploring the efficacy and safety of tranexamic acid in acute intracerebral hemorrhage. Baseline and 24-hour computed tomography scans of trial participants were analyzed. Hematoma expansion was defined as an increase in hematoma volume of >33% or >6 mL on 24-hour computed tomography. Poor functional outcome was defined as modified Rankin Scale of 4 to 6 at day 90. Multivariable logistic regression was performed to identify predictors of hematoma expansion and poor functional outcome. Results- Of 2325 patients recruited, 2077 (89.3%) had valid baseline and 24-hour scans. Five hundred seventy patients (27.4%) had hematoma expansion while 1259 patients (54.6%) had poor functional outcome. The prevalence of noncontrast computed tomography signs was blend sign, 366 (16.1%); black hole sign, 414 (18.2%); island sign, 200 (8.8%); and hypodensities, 701 (30.2%). Blend sign (adjusted odds ratio [aOR] 1.53 [95% CI, 1.16-2.03]; P=0.003), black hole (aOR, 2.03 [1.34-3.08]; P=0.001), and hypodensities (aOR, 2.06 [1.48-2.89]; P<0.001) were independent predictors of hematoma expansion on multivariable analysis with adjustment for covariates. Black hole sign (aOR, 1.52 [1.10-2.11]; P=0.012), hypodensities (aOR, 1.37 [1.05-1.78]; P=0.019), and island sign (aOR, 2.59 [1.21-5.55]; P=0.014) were significant predictors of poor functional outcome. Tranexamic acid reduced the risk of hematoma expansion (aOR, 0.77 [0.63-0.94]; P=0.010), but there was no significant interaction between the presence of noncontrast computed tomography signs and benefit of tranexamic acid on hematoma expansion and functional outcome (P interaction all >0.05). Conclusions- Blend sign, black hole sign, and hypodensities predict hematoma expansion while black hole sign, hypodensities, and island signs predict poor functional outcome. Noncontrast computed tomography signs did not predict a better response to tranexamic acid. Clinical Trial Registration- URL: https://www.isrctn.com. Unique identifier: ISRCTN93732214.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Law ZK, Ali A, Krishnan K, et al. Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage. Stroke. 2019. PMID: 31735141. doi:10.1161/STROKEAHA.119.026128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。